Asthma and pregnancy in the 2020 decade: still a matter of concern

J Matern Fetal Neonatal Med. 2022 Dec;35(25):6498-6504. doi: 10.1080/14767058.2021.1916462. Epub 2021 Apr 29.

Abstract

Asthma is a fairly common health problem for pregnant women and a potentially serious medical condition that may complicate pregnancy. Most complications are related to lack of disease control, which can adversely affect both maternal quality of life and perinatal outcomes. In this article, we review recent literature concerning asthma in pregnancy, describing the course of the disease and associated complications. Furthermore, we review and discuss asthma monitoring and management during pregnancy, labor and post-partum. The course of asthma symptoms during pregnancy is unpredictable but exacerbations are more common during the second trimester. The causes are multifactorial and asthma phenotype may have a role. It has been proposed that combined use of CARAT (Control of Allergic Rhinitis and Asthma Test) and lung function tests can be used to monitor and adjust therapy during pregnancy in patients with asthma. As a complement, an approach that considers airway inflammation assessment using fractional exhaled nitric oxide (FeNO), a noninvasive marker of inflammation, may improve asthma control during pregnancy. It is important to consider a few but relevant differences in asthma management and treatment regarding pregnancy and the peri-partum period to safely achieve optimal management of asthma during all these phases for both mother and offsprings.

Keywords: Asthma; control; management; pregnancy; safety; treatment.

Publication types

  • Review

MeSH terms

  • Asthma* / diagnosis
  • Asthma* / epidemiology
  • Asthma* / therapy
  • Breath Tests*
  • Female
  • Humans
  • Inflammation
  • Nitric Oxide
  • Pregnancy
  • Quality of Life

Substances

  • Nitric Oxide